Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Share-based Compensation Growth (3y) (2020 - 2026)

Analysis

Catheter Precision (VTAK) Share-based Compensation Growth (3y) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 8.37%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -22.92%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 19.64%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -28.31%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 0.55%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 4.11%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 7.30%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -0.59%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 3.40%
10 Catheter Precision 480,427.59 -1.36 Mn 98,000.00 12.63%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.63%
Mar 31, 2026 -25.17%
Dec 31, 2025 -286.10%
Sep 30, 2025 103.10%
Jun 30, 2025 147.51%
Mar 31, 2025 115.06%
Dec 31, 2024 -59.45%
Sep 30, 2024 -32.29%
Jun 30, 2024 -47.61%
Mar 31, 2024 -19.29%
Dec 31, 2023 -26.09%
Sep 30, 2023 307.54%
Jun 30, 2023 -59.30%
Mar 31, 2023 -24.76%
Dec 31, 2022 -91.07%
Sep 30, 2022 -77.90%
Jun 30, 2022 -73.33%
Mar 31, 2022 -72.28%
Dec 31, 2021 -67.70%
Sep 30, 2021 -45.36%